Subtopic Deep Dive
Chronic Hepatitis E in immunocompromised patients
Research Guide
What is Chronic Hepatitis E in immunocompromised patients?
Chronic Hepatitis E in immunocompromised patients refers to persistent HEV infections, often genotype 3, in organ transplant recipients and others with impaired immunity, leading to risks of cirrhosis and extrahepatic manifestations.
Studies document chronic HEV in kidney transplant patients progressing to cirrhosis (Gerolami et al., 2008, 353 citations). Viral evolution includes insertions in the polyproline region in chronically infected individuals (Lhomme et al., 2020, 421 citations). Over 20 papers since 2008 detail diagnostics, ribavirin therapy, and outcomes in this population.
Why It Matters
Chronic HEV complicates transplant medicine, with Gerolami et al. (2008) reporting cirrhosis in a kidney recipient, necessitating screening protocols. Kamar et al. (2017, 557 citations) highlight therapeutic responses to ribavirin, impacting survival rates. Wedemeyer et al. (2012, 326 citations) emphasize antiviral needs, guiding immunosuppression adjustments in solid organ transplants.
Key Research Challenges
Diagnostic Delays
Immunocompromised patients often lack typical symptoms, delaying HEV RNA detection (Kamar et al., 2017). Serology fails due to impaired antibody responses (Wedemeyer et al., 2012). Persistent viremia requires repeated PCR testing (Gerolami et al., 2008).
Viral Evolution Mechanisms
HEV develops insertions/duplications in polyproline region, aiding chronicity (Lhomme et al., 2020). These genomic changes correlate with immune evasion in transplants. Understanding quasispecies dynamics remains incomplete (Kamar et al., 2017).
Ribavirin Resistance
Variable responses to ribavirin occur in solid organ recipients (Wedemeyer et al., 2012). Treatment failures link to high viral loads and mutations. Optimized dosing protocols are lacking (Kamar et al., 2017).
Essential Papers
Hepatitis E virus infection
Nassim Kamar, Jacques Izopet, Nicole Pavio et al. · 2017 · Nature Reviews Disease Primers · 557 citations
Hepatitis E and pregnancy: understanding the pathogenesis
Udayakumar Navaneethan, Mayar Al Mohajer, Mohamed Tarek M. Shata · 2008 · Liver International · 421 citations
Abstract Hepatitis E virus (HEV) is a single‐stranded RNA virus that causes large‐scale epidemics of acute viral hepatitis, particularly in developing countries. In men and non‐pregnant women, the ...
Insertions and Duplications in the Polyproline Region of the Hepatitis E Virus
Sébastien Lhomme, Florence Nicot, Nicolas Jeanne et al. · 2020 · Frontiers in Microbiology · 421 citations
Recombinant strains of hepatitis E virus (HEV) with insertions of human genomic fragments or HEV sequence duplications in the sequence encoding the polyproline region (PPR) were previously describe...
Long-Term Efficacy of a Hepatitis E Vaccine
Jun Zhang, Xuefeng Zhang, Shoujie Huang et al. · 2015 · New England Journal of Medicine · 368 citations
Immunization with this hepatitis E vaccine induced antibodies against HEV and provided protection against hepatitis E for up to 4.5 years. (Funded by the Chinese Ministry of Science and Technology ...
Chronic Hepatitis E with Cirrhosis in a Kidney-Transplant Recipient
René Gerolami, Valérie Moal, Philippe Colson · 2008 · New England Journal of Medicine · 353 citations
Chronic Hepatitis E with Cirrhosis in a Kidney-Transplant RecipientTo the Editor: Hepatitis E virus (HEV) is an important cause of acute viral hepatitis worldwide. 1Kamar et al. in this issue of th...
Hepatitis E virus: advances and challenges
Ila Nimgaonkar, Qiang Ding, Robert E. Schwartz et al. · 2017 · Nature Reviews Gastroenterology & Hepatology · 340 citations
Pathogenesis and Treatment of Hepatitis E Virus Infection
Heiner Wedemeyer, Sven Pischke, Michael P. Manns · 2012 · Gastroenterology · 326 citations
Reading Guide
Foundational Papers
Start with Gerolami et al. (2008, 353 citations) for first cirrhosis case in kidney transplant; Wedemeyer et al. (2012, 326 citations) for pathogenesis and ribavirin; Kamar et al. (2011, 310 citations) for neurologic complications.
Recent Advances
Lhomme et al. (2020, 421 citations) on polyproline insertions/duplications; Kamar et al. (2017, 557 citations) comprehensive primer; Purdy et al. (2022, 281 citations) on Hepeviridae taxonomy.
Core Methods
HEV RNA PCR quantification; next-gen sequencing for quasispecies; ribavirin 600-1000mg/day for 3-6 months; liver biopsy for fibrosis staging (Kamar et al., 2017; Wedemeyer et al., 2012).
How PapersFlow Helps You Research Chronic Hepatitis E in immunocompromised patients
Discover & Search
Research Agent uses searchPapers for 'chronic HEV immunocompromised' retrieving Kamar et al. (2017, 557 citations), then citationGraph maps 50+ citing works on transplant outcomes, and findSimilarPapers uncovers Lhomme et al. (2020) on viral insertions.
Analyze & Verify
Analysis Agent applies readPaperContent to extract ribavirin efficacy data from Wedemeyer et al. (2012), verifies claims via CoVe against Gerolami et al. (2008), and runPythonAnalysis with pandas computes meta-analysis of viremia clearance rates across 10 papers, graded by GRADE for evidence strength.
Synthesize & Write
Synthesis Agent detects gaps in resistance mechanisms post-Lhomme et al. (2020), flags contradictions in neurologic risks (Kamar et al., 2011), then Writing Agent uses latexEditText, latexSyncCitations for Gerolami et al. (2008), and latexCompile to produce a review manuscript with exportMermaid timelines of HEV progression.
Use Cases
"Statistical outcomes of ribavirin in HEV kidney transplants"
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas meta-analysis of clearance rates from Kamar et al. 2017 and Wedemeyer et al. 2012) → CSV export of survival curves.
"Draft review on chronic HEV progression to cirrhosis"
Synthesis Agent → gap detection → Writing Agent → latexEditText (structure sections), latexSyncCitations (Gerolami et al. 2008), latexCompile → PDF manuscript with citations.
"Find code for HEV quasispecies analysis in chronic cases"
Research Agent → paperExtractUrls (Lhomme et al. 2020) → Code Discovery → paperFindGithubRepo → githubRepoInspect → Python scripts for polyproline insertion phylogenies.
Automated Workflows
Deep Research workflow scans 50+ papers via searchPapers on 'chronic HEV transplant', structures report with GRADE-graded ribavirin efficacy from Kamar et al. (2017). DeepScan applies 7-step CoVe to verify viral evolution claims in Lhomme et al. (2020) against Gerolami et al. (2008). Theorizer generates hypotheses on resistance from Wedemeyer et al. (2012) patterns.
Frequently Asked Questions
What defines chronic Hepatitis E in immunocompromised patients?
Chronicity is persistent HEV RNA >3 months in transplant recipients or HIV patients, often genotype 3 (Kamar et al., 2017).
What methods diagnose chronic HEV?
Quantitative HEV RNA PCR is essential; IgM/IgG serology unreliable in immunosuppression (Wedemeyer et al., 2012).
What are key papers?
Gerolami et al. (2008, 353 citations) first reported cirrhosis case; Kamar et al. (2017, 557 citations) reviews infections; Lhomme et al. (2020, 421 citations) details polyproline insertions.
What open problems exist?
Ribavirin resistance mechanisms unclear; no approved antivirals; need for vaccines in immunocompromised (Wedemeyer et al., 2012).
Research Hepatitis Viruses Studies and Epidemiology with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Chronic Hepatitis E in immunocompromised patients with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers